Skip to main content

Dissolvable Sutures Market is Growing at a Healthy CAGR During Forecast to 2023

Market Highlights:
Dissolvable sutures are stitches that doctors and surgeons, use to hold skin, internal organs, blood vessels, and all other tissues of the human body together, after the injury, incision, or surgery. These sutures have an anticipated advantage as they are broken down in the body tissue after a given period, and no foreign material is left inside the patient's body.
The global Dissolvable Sutures Market Growth is driven by the growing aging population, increasing incidences of chronic diseases, rising healthcare expenditure, increasing number of surgeries and burns, and rising number of hospitals. In addition, immense technological advancements in material science and increasing occurrences of musculoskeletal diseases are likely to propel the market growth during the forecast period.

Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6081

Despite the drivers, the development of advanced wound care dressings and availability of alternatives such as surgical staplers and complications such as hemorrhage and leakage especially in esophageal and colonic anastomosis are a few factors restraining the growth of the dissolvable sutures market. Furthermore, stringent government regulations and increasing preference for minimally invasive surgical procedures are the constraints limiting the market growth.
Many prominent players currently dominate the global dissolvable sutures market. For instance, in April 2017 Medtronic Plc signed an agreement to divest a portion of its patient monitoring & recovery division to Cardinal Health for 6.1 USD billion. In this agreement, the company intends to include 17 dedicated manufacturing facilities among the product line such as dental/animal health, chart paper, wound care, incontinence, electrodes, and sharp safety offerings.
Global Dissolvable Sutures Key Players:
  • Braun Melsungen AG
  • Boston Scientific Corporation
  • DemeTECH Corporation
  • ENDOEVOLUTION LLC
  • Hu-Friedy Mfg. Co
  • Internacional Farmacéutica S.A. De C.V
  • Johnson & Johnson Services
  • Medline Industries
  • Medtronic
  • Péters Surgical
  • Roboz Surgical Instrument Co
Segmentation:
  • The global dissolvable sutures market is segmented on the basis of type, application, and end-user.
  • On the basis of type, the market is classified as natural dissolvable sutures and synthetic dissolvable sutures. Natural dissolvable sutures are further segmented as catgut plain sutures and catgut chromic sutures.
  • The global dissolvable sutures market on the basis of application is segmented into cardiovascular surgeries, general surgeries, gynecological surgeries, orthopedic surgeries, ophthalmic surgeries, and others.
  • On the basis of end-user, the global dissolvable sutures market is segmented into ambulatory surgical centers, hospitals, clinics, and others.
Regional Analysis:
The global dissolvable sutures market consists of four regions, namely, Americas, Europe, Asia Pacific, and the Middle East and Africa. North America holds the highest market share in the global dissolvable sutures market owing to the higher adoption of technologically advanced products for surgical procedures in the region, increase in the prevalence of various chronic diseases, and the development of the wound management sector. In addition, according to the Centers for Disease Control and Prevention, in 2015, an approximate 2.8 million people were hospitalized due to injuries in the United States.
Europe holds the second position in the global dissolvable sutures market. The availability of funds for research, increasing healthcare spending, huge patient population, and government support for research and development drive the European market. For instance, according to the National Statistics in 2015, the healthcare spending in the U.K. reached 271.6 USD billion in 2015 from 262.2 USD billion in 2014. Furthermore, the presence of developed countries such as Germany and the U.K. within the region is expected to fuel the market growth during the forecast period.

NOTE : Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.

Comments

Popular posts from this blog

Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis and Forecast to 2023

Market Overview: The Global Respiratory Therapeutic Devices Market is predicted to scale to new heights and expand at a CAGR of 10.8% over the forecast period of 2017-2023, asserts Market Research Future (MRFR) in an in-depth study.                   The growth of the Global Covid 19 Analysis on Respiratory Therapeutic Devices Market Analysis   is primarily led by the recent surge in the incidence of chronic respiratory diseases such as asthma, COPD, and sleep disorder breathing. As per the estimates of the World Health Organization (WHO), approximately 235 Mn people suffered from asthma in 2017 across the globe. The growing burden of chronic respiratory diseases (CRDs) induces strong demand for respiratory therapeutic devices within the market. Moreover, with the increase in the global aging population, there is a greater need for respiratory therapeutic devices.     ...

Antibody Drug Conjugate Market is Presumed to Grow at a Reliable CAGR of 19% During Forecast to 2023

Antibody Drug Conjugate Market Analysis: Various factors are adding to the global antibody drug conjugate market share. These factors, as per the new MRFR report, include advances in medical technology, rising cases of cancer, growing obese population, and increasing aging population. Additional factors adding market growth include increasing collaborations between biotechnology companies, biopharmaceuticals, and research institutes, rising R&D on oncology diseases, increasing research on advanced drug discoveries, rising number of research on antibody therapies, and preclinical research. The global Antibody Drug Conjugate Market Share is likely to grow at a 19% CAGR between 2017- 2023 , reveals the new Market Research Future (MRFR) report. Antibody drug conjugates are new-age therapeutic agents that have three parts- a chemical linker to attach cytotoxic agents to antibodies, cytotoxic agents for killing target cancer cells, and specific antibodies for binding. Lymphoma, mult...

Desalting and Buffer Exchange Market is Growing at a Healthy CAGR of 10.5% During Forecast to 2023

Market Highlights: The Global Desalting and Buffer Exchange Market is anticipated to have held a market value of USD 615.20 million in the year 2017 and is expected to grow at a CAGR of 10.5% during the forecast period. Desalting and buffer exchange play a key role in biotechnological companies. Buffer exchange is used to place a protein solution into a more suitable buffer before applications such as electrophoresis, ion exchange, affinity chromatography among others. Get a Free Sample @ https://www.marketresearchfuture.com/sample_request/6633 Buffer exchange is the term used when one set of buffer salts in a sample is exchanged by another more appropriate buffer set. The rising demand for monoclonal antibodies, growing research and development expenditure by the biopharmaceutical companies, and rising focus on proteomic and genomic research is anticipated to boost the growth of the market over the forecast period. However, the dearth of skilled professionals is excepted to ...